🔴According to the clinical trial results announcement disclosed by the company on November 20, combined with the contents of the telephone conference held on the same day, the results of the clinical trial are summarized below.
⭕My conclusion is bullish. The stock price fell today, perhaps to clear unstable chips for the next round of upward movement. Currently, the long-term moving average is strong support. After thorough cleaning, there will be a period of consolidation, followed by another uptrend, then a new round of financing to raise funds for commercialization outside Europe and further expansion of phase III clinical trials for NDA new drug applications. Of course, the possibility of the company being acquired at a substantial premium cannot be ruled out. Turbo is heavily weighted, continue to hold.
🔴Intoday's telephone conference, company management and Professor John Kastelein emphasized the synergistic effect of obicetrapib when used in combination with evolocumab. This means that the combined effect of the drugs is superior to the sum of the effects of the two drugs used alone. The management stated that the positive results of the TANDEM trial have strengthened the company's confidence in the ongoing PREVAIL trial. Once PREVAIL is successful in the future, the company valuation is expected to double.
————
🔥Interpretation of TANDEM Trial Results🔥
🔴Primary Endpoint: Percentage Reduction in LDL-C
Day 84:
Monotherapy with Evymlozumab: LDL-C decreased by 23.3% compared to placebo.
Monotherapy with Obicetrapib: LDL-C decreased by 31.5% compared to placebo.
O...

$NextEra Energy (NEE.US)$ beautiful shakeout today. this is setting up for a swing. could have entered today at the close for 1st day swing but missed it.

Using the performance of the funds for the eventful Oct as a guage, I would say that $LionGlobal Singapore Trust Fund (SG9999002406.MF)$ appears to be robust enough to lead the pack in November.
Looking at the composition of this fund, DBS, which is now at all time high, is major component, eclipsing the REITS  components (CICT, MLT) which are taking a hit otherwise the relative stability of Singapore economy and of the holdings under the fund should enable the ...

Genting Highlands offers equivalent prices and quantities, with QR codes.
$GENTING (3182.MY)$ $GENM (4715.MY)$
Genting Highlands offers equivalent prices and quantities, with QR codes.

$Voyager Therapeutics (VYGR.US)$
Very oversold, less than 1% profitable positions, undervalued by all except p/e which is still under market avg.

$Elevai Labs (ELAB.US)$ Today the price may be red unless there is good news. Can be ready to buy if the price falls. Most importantly, I hope RS does not occur.